H

Hemant Surgical Industries Ltd
BSE:543916

Watchlist Manager
Hemant Surgical Industries Ltd
BSE:543916
Watchlist
Price: 293.4 INR 2.95%
Market Cap: ₹3.8B

Net Margin

7.5%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
7.5%
=
Net Income
₹80.4m
/
Revenue
₹1.1B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
7.5%
=
Net Income
₹80.4m
/
Revenue
₹1.1B

Peer Comparison

Country Company Market Cap Net
Margin
IN
Hemant Surgical Industries Ltd
BSE:543916
3.8B INR
Loading...
US
Mckesson Corp
NYSE:MCK
116.7B USD
Loading...
US
Cencora Inc
NYSE:COR
71.1B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
70.7B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
53B USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
35B AUD
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
9.6B USD
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
64.3B CNY
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
63.9B CNY
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
66.4B HKD
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...

Market Distribution

In line with most companies in India
Percentile
58th
Based on 5 531 companies
58th percentile
7.5%
Low
-305 007.7% — 2.1%
Typical Range
2.1% — 11.6%
High
11.6% — 1 221 633.3%
Distribution Statistics
India
Min -305 007.7%
30th Percentile 2.1%
Median 5.8%
70th Percentile 11.6%
Max 1 221 633.3%

Hemant Surgical Industries Ltd
Glance View

Market Cap
3.8B INR
Industry
Health Care

Hemant Surgical Industries Ltd. operates as a pharmaceutical company. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2023-06-05. The firm's product offerings cover a spectrum of equipment and disposables required for renal care, cardiovascular disease, respiratory disease, critical care and radiology and surgical disposables. Its range of products includes the indigenously manufactured products along with some other products that are imported from countries, such as Japan, China and France, Australia and are further processed in our assembly units. Its product categories include Aero Healthcare Products, JMS Products, Dialysis Products and Covid Care Products. Its services include home dialysis treatment, home dialysis solution on outright purchase, turnkey dialysis center setup, dialysis center management, dialysis machine on a rental basis, AMC/CMC contract for the dialysis machine and oxygen concentrator on a rental basis.

HSIL Intrinsic Value
188.27 INR
Overvaluation 36%
Intrinsic Value
Price
H
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
7.5%
=
Net Income
₹80.4m
/
Revenue
₹1.1B
What is Hemant Surgical Industries Ltd's current Net Margin?

The current Net Margin for Hemant Surgical Industries Ltd is 7.5%, which is in line with its 3-year median of 7.5%.

How has Net Margin changed over time?

Over the last 0 months, Hemant Surgical Industries Ltd’s Net Margin has decreased from 7.5% to 7.5%. During this period, it reached a low of 7.5% on Apr 3, 2025 and a high of 7.5% on Apr 3, 2025.

Back to Top